Life Scientist > Biotechnology

TGA approves Moderna vaccine in Aus adults

10 August, 2021

The TGA has granted provisional approval to Moderna Australia for its COVID-19 vaccine, Spikevax (elasomeran).


Restorative hydrogel offers hope for Parkinson's patients

06 August, 2021

The new material is made from natural amino acids and acts as a gateway to facilitate the safe transfer of stem cells into the brain and restore damaged tissue.


COVID-19 nasal spray trial seeks participants in Sydney

21 July, 2021

ENA Respiratory has initiated a Phase I human safety study in Sydney for its first-in-class nasal spray for the prevention of COVID-19.


Tetanus neurotoxin could treat depression, Parkinson's, ALS

19 July, 2021

A non-toxic derivative of the tetanus neurotoxin (Hc-TeTx) may serve to treat depression and neurodegenerative diseases, as demonstrated in animal models.


Treatment found to reverse dementia in mice

05 July, 2021

The SAK3 molecule appeared to help improve memory and learning in a mouse model of Alzheimer's disease.


Edible cholera vaccine candidate made of powdered rice

01 July, 2021

A new vaccine to protect against deadly cholera has been made by grinding up genetically modified grains of rice.


COVID-19 DNA vaccine trial commences Down Under

29 June, 2021

Researchers are set to commence the first Phase 1 human trial of a COVID-19 gene-based DNA vaccine in Australia, delivered via a needle-free system.


Monash to manufacture mRNA COVID-19 vaccine for Phase 1 trials

22 June, 2021

Monash University has received $5 million from the Victorian Government to manufacture the first Australian batch of a COVID-19 mRNA vaccine for clinical trials.


Novavax's Phase 3 vaccine trial yields promising results

17 June, 2021

Novavax's COVID-19 vaccine demonstrated 100% protection against moderate and severe disease, with 90.4% efficacy overall, in the PREVENT-19 Phase 3 trial.


Researchers 'trick' stem cells into becoming bone

09 June, 2021

Researchers have found a way to alter the shape and nucleus of individual stem cells, which could speed up recovery following bone replacements.


Hydrogel treats wounds, protects against bacteria

31 May, 2021

A specially designed hydrogel prevents infections in wounds and works against all types of bacteria — including antibiotic-resistant ones.


Newly designed drug compound to stop malaria in its tracks

26 May, 2021

Scientists have developed a set of compounds designed to stop the malaria parasite being able to burst out of red blood cells — a process vital to its replication and life cycle.


Australia secures 25 million Moderna vaccines

13 May, 2021

The government has secured 25 million doses of the Moderna COVID-19 vaccine to further diversify its vaccine portfolio, as well as to provide access to a booster or variant vaccine.


Electrically activated glue used to seal broken blood vessels

07 May, 2021

A new device offers a way to seal tears and holes in blood vessels, using an electrically activated glue patch applied via a minimally invasive balloon catheter.


Lab-created heart valves grow with the recipient

03 May, 2021

If confirmed in humans, the new heart valves could prevent the need for repeated valve replacement surgeries in thousands of children each year.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd